Tectonic Therapeutic (TECX) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Apr, 2026Executive summary
Annual meeting scheduled for June 8, 2026, with voting open until June 7, 2026, at 11:59 PM ET.
Shareholders can access proxy materials online or request paper/email copies by May 25, 2026.
Meeting will be held virtually, allowing remote participation and voting.
Voting matters and shareholder proposals
Election of two directors: Timothy A. Springer, Ph.D., and Stefan Vitorovic, M.S., M.B.A.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on compensation of Named Executive Officers.
Provision for other business to be addressed as may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director nominees and auditor ratification.
Latest events from Tectonic Therapeutic
- Net loss widened to $22.3M in Q2 2026 as R&D spending rose; cash reserves at $227.1M.TECX
Q2 2026 - Advancing GPCR-targeted biologics for PH and HHT with strong clinical progress and market potential.TECX
Investor presentation - TX45 demonstrated robust efficacy and safety in PH-HFpEF, targeting a large unmet need.TECX
TD Cowen 45th Annual Healthcare Conference - All proposals passed, with directors reelected and auditor ratified; no shareholder questions.TECX
AGM 2026 - TX45 and TX2100 advance as differentiated GPCR biologics for high-value, underserved markets.TECX
Investor presentation - Q1 2026 net loss rose to $25.2M as R&D spending increased; cash runway extends into Q4 2028.TECX
Q1 2026 - Director elections, auditor ratification, and executive pay are key items at the 2026 virtual meeting.TECX
Proxy filing - TX45 and TX2100 advance in the clinic, with differentiated strategies and strong preclinical data.TECX
Leerink Global Healthcare Conference 2026 - Advancing novel therapies for pulmonary hypertension and HHT, with pivotal data expected by 2027.TECX
TD Cowen 46th Annual Health Care Conference